Prosecution Insights
Last updated: October 02, 2026
Application No. 17/898,771

Dye Printing Treatment Liquid Composition, Composition Set, Printing Method, And Ink Jet Printing Method

Non-Final OA §103
Filed
Aug 30, 2022
Priority
Aug 31, 2021 — JP 2021-140883
Examiner
KHAN, AMINA S
Art Unit
1761
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Seiko Epson Corporation
OA Round
3 (Non-Final)
48%
Grant Probability
Moderate
3-4
OA Rounds
0m
Est. Remaining
90%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
494 granted / 1039 resolved
-17.5% vs TC avg
Strong +43% interview lift
Without
With
+43.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
54 currently pending
Career history
1096
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
64.3%
+24.3% vs TC avg
§102
9.8%
-30.2% vs TC avg
§112
17.8%
-22.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1039 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on August 20, 2026 has been entered. Claims 2,3,5 and 7-9 are pending. Claims 1,4 and 6 have been cancelled. Claims 8 and 9 have been amended. Claims 2,3,5 and 7 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to nonelected inventions, there being no allowable generic or linking claim. All prior rejections are withdrawn in view of applicant’s amendments to the claim. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 8 and 9 are rejected under 35 U.S.C. 103 as being unpatentable over Pinto (US 2011/0169901) in view of Takahashi (WO 2006129604) and Fujii (US 2021/0388225). Pinto teaches ink-jet printing for sublimation printing of textile fiber substrates, wherein fibers are pretreated with aqueous polyester coating compositions and a sublimation transfer print is applied to a transfer sheet which has ink inkjet printed on it and the ink is transferred from the transfer sheet to the pretreated fabric (paragraph 0013, 0015,0021,0024,0026,0027, 0049). Pinto teaches printing cotton or polyester fabrics (hydroxyl containing fibers, paragraphs 0048) wherein the ink applied during sublimation transfer is a disperse dye containing ink (paragraph 0024). Pinto does not teach the glass transition temperature of the polyester resin and a polyester resin with a crosslinking agent. Takahashi teaches that polyester resins (paragraph 0014) are preferably combined with water (paragraph 0014) and crosslinking agents such as isocyanates (paragraph 0016) to form dyeable pretreatment coating layers on textiles such as cotton (paragraph 0002, 0003) before they receive sublimation transfer inks containing disperse dyes (paragraph 0017,0022) by ink jet application (paragraph 0022). Takahashi teaches that the isocyanate is preferably 60-75% by weight of the total amount of the polyester resin and isocyanate mixture (40:60 ratio, 1:1.5 ratio). Fujii teaches that pretreatment liquids containing water, (paragraph 0342), polyester resins with sulfonic acid groups such as Plascoat Z687 (applicant’s preferred polyester resin with sulfonic acid groups, see applicant’s pgpub paragraph 0152; Fujii paragraph 0365) and glass transition temperatures of 30-120°C (paragraph 0345-0349) and known additives (paragraph 0380). Fujii teaches pretreatment liquids containing polyester resins such as PLASCOAT Z687 and with Tg values of 110°C-120°C are effective in enhancing image quality and improving rub resistance (paragraph 0019). Fujii teaches applying to polyethylene terephthalate bases (polyester; paragraph 0404). It would have been obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Pinto by incorporating a isocyanate crosslinking agent and a polyester resin of glass transition temperature 110°C or more with sulfonic acid groups in a pretreatment layer on the cotton (hydroxyl containing) fabric followed by transfer printing onto the pretreated fabric by applying a transfer sheet containing an ink-jetted disperse dye, polyester resin, isocyanate crosslinker and water and transferring the ink image using thermocompression to arrive at a ink printed polyester pretreated fabric as Takahashi teaches pretreatments with polyester resins, isocyanate crosslinking agents and water provide an image receiving area with an coating texture that is hardly impaired and that the amounts of the isocyanate impact the suppression of the bleeding and blurring of the transferred image, image stabilization, suppression of sticking to the transfer sheet and improve the heat resistance. While Takahashi teaches 1:1.5 weight ratio of polyester resin to isocyanate crosslinker is preferred, this is a preferred embodiment and lower ratios such as 1:1.2 can also be used. The reference is not limited to only preferred embodiments. All disclosures of the prior art, including non-preferred embodiment, must be considered. See In re Lamberti and Konort, 192 USPQ 278 (CCPA 1967); In re Snow 176 USPQ, 328, 329 (CCPA 1973). Non-preferred embodiments can be indicative of obviousness, see Merck & Co. v. Biocraft Laboratories Inc. 10 USPQ 2d 1843 (Fed. Cir. 1989); In re Lamberti, 192 USPQ 278(CCPA 1976); In re Kohler, 177 USPQ 399. It would have been further obvious to one of ordinary skill in the art at the time the invention was made to modify the methods of Pinto by using the polyester resins of the claimed glass transition temperatures and containing sulfonic acid groups in the pretreatment liquid as Fujii teaches pretreatment liquids containing polyester resins such as PLASCOAT Z687 and with Tg values of 110°C-120°C are effective in enhancing image quality and improving rub resistance. Applying the pretreatment liquid containing the claimed polyester resin particles onto the fabric would have the same effect as applying it to a transfer sheet and then transfer printing the ink to the fabric as Fujii teaches applying to the same polyester polymer materials. Response to Arguments Applicant’s arguments with respect to the new rejection have been considered but are not persuasive. Takahashi teaches combining polyester resins with isocyanate crosslinkers to provide an image receiving area with a coating texture that is hardly impaired and that the amounts of the isocyanate impact the suppression of the bleeding and blurring of the transferred image, image stabilization, suppression of sticking to the transfer sheet and improve the heat resistance. While Takahashi teaches 1:1.5 weight ratio of polyester resin to isocyanate crosslinker is preferred, this is a preferred embodiment and lower ratios such as 1:1.2 can also be used. The reference is not limited to only preferred embodiments. All disclosures of the prior art, including non-preferred embodiment, must be considered. See In re Lamberti and Konort, 192 USPQ 278 (CCPA 1967); In re Snow 176 USPQ, 328, 329 (CCPA 1973). Non-preferred embodiments can be indicative of obviousness, see Merck & Co. v. Biocraft Laboratories Inc. 10 USPQ 2d 1843 (Fed. Cir. 1989); In re Lamberti, 192 USPQ 278(CCPA 1976); In re Kohler, 177 USPQ 399. Applicant’s allegation of unexpected results is not supported by data commensurate in scope with the claims demonstrating superiority for a particular ratio, rather applicant only refers to a conclusory statement in paragraph 0045 of the specification which is not sufficient. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMINA S KHAN whose telephone number is (571)272-5573. The examiner can normally be reached Monday-Friday, 9am-5:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Angela Brown-Pettigrew can be reached at 571-272-2817. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AMINA S KHAN/Primary Examiner, Art Unit 1761
Read full office action

Prosecution Timeline

Aug 30, 2022
Application Filed
Oct 31, 2025
Non-Final Rejection mailed — §103
Jan 21, 2026
Response Filed
Jun 04, 2026
Final Rejection mailed — §103
Aug 20, 2026
Request for Continued Examination
Aug 25, 2026
Response after Non-Final Action
Sep 03, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12703725
Silk-Based Products, Formulations, and Methods of Use
4y 3m to grant Granted Aug 11, 2026
Patent 12703887
METHOD FOR THE ANTIMICROBIAL PROTECTION OF HIDES DURING THE TANNING PROCESS WHICH INCLUDES A BIOCIDAL COMPOSITION AND A LUMINESCENT ADDITIVE ALLOWING THE IDENTIFICATION THEREOF
1y 12m to grant Granted Aug 11, 2026
Patent 12680226
ANTIBACTERIAL AND ANTIVIRAL FABRIC
3y 9m to grant Granted Jul 14, 2026
Patent 12617964
DIGITAL PRINTED FABRIC, MANUFACTURING METHOD FOR DIGITAL PRINTED FABRIC, AND DIGITAL PRINTING INK
3y 11m to grant Granted May 05, 2026
Patent 12606952
METHOD FOR PRODUCING MODIFIED CELLULOSE FIBER, AND MODIFIED CELLULOSE FIBER
5y 5m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
48%
Grant Probability
90%
With Interview (+43.0%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 1039 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month